The new measures, “Persistent Indicators of Dementia without a Diagnosis—Long Stay” and “Persistent Indicators of Dementia without a Diagnosis—Short Stay,” complement existing Centers for Medicare & Medicaid Services (CMS) quality measures. Information including mental status, depression and delirium are captured by the Minimum Data Set 3.0 for the measures.
A diagnosis of dementia affects the medications, care plans and treatment that are appropriate for long-term care residents. But unrecognized or undiagnosed dementia can lead to poor coordination and a failure to provide care designed to promote quality of life.
In a release, AMDA Past President James Lett, II, MD, CMD said, “The new AMDA measures are a first step in identifying, then addressing a major enemy of good patient care.”
An appeals period will run through April 4, 2013 before final implementation.